The development, assessment, and application of therapies for the prevention of cardiovascular disease complications, especially in the population of patients with type 2 diabetes mellitus.
RESEARCH INTERESTS
Diabetes and cardiovascular disease
Application of evidence-based therapies
Cardiovascular risk modification
Cardiovascular risk assessment
RECENT PUBLICATIONS
Newby LK, Kristinsson A, Bhapkar MV, Aylward PE, Dimas AP, Klein WW, McGuire DK, Moliterno DJ, Verheugt FWA, Weaver WD, Califf RM, for the SYMPHONY and 2nd SYMPHONY Investigators, "Early statin use and outcomes in patients with acute coronary syndromes." JAMA, 287:3087-3095, 2002
McGuire DK, Levine BD, Williamson JW, Snell PG, Blomqvist CG, Saltin B, Mitchell JH, "A 30-year follow-up of the Dallas bed rest and training study: Effect of age on the cardiovascular response to exercise" Circulation, 104:1350-1357, 2001
Labinaz M, Madan M, OShea JC, Kilaru R, Chin W, Pieper K, McGuire DK, Saucedo J, Talley JD, Liu H, Kitt MM, Califf RM, Tcheng JE, for the ESPRIT Investigators, "One-year Outcomes of Diabetic Patients Following Coronary Stenting:Results from the Enhanced Suppression of the Platelet IIb/IIIa Receptor withIntegrilin Therapy (ESPRIT) Trial" Am J Cardiol, 90:585-590, 2002
McGuire DK, Levine BD, Williamson JW, Snell PG, Blomqvist CG, Saltin B, Mitchell JH, "A 30-year follow-up of the Dallas bed rest and training study: Effect of age on the cardiovascular adaptation to exercise training" Circulation, 104:1358-1366, 2001
McGuire DK, Anstrom KA, Peterson ED, "The influence of the BARI NHLBI diabetic clinical alert on practice patterns: Results from the National Cardiovascular Network database." Circulation, In Press, 2003
Point and right click (click and hold for Mac users) your mouse onand select "Save this link (or target) as..." option to save the file to your local computer.